Open AccessClinimetallomics: Arsenic Speciation in Urine from Patients With Arsenism by HPLC-ICP-MS
Author(s) -
Huiling Li
Publication year - 2021
Publication title -
atomic spectroscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.294
H-Index - 30
eISSN - 2708-521X
pISSN - 0195-5373
DOI - 10.46770/as.2021.103
Subject(s) - arsenic , chemistry , urine , arsenic poisoning , chromatography , inductively coupled plasma mass spectrometry , genetic algorithm , environmental chemistry , detection limit , mass spectrometry , biochemistry , organic chemistry , evolutionary biology , biology
Clinimetallomics is proposed as a branch of metallomics that focuses on the study of the metallome in clinical samples of urine, blood, and tissues. As the clinical diagnosis of arsenic poisoning is mainly based on the concentration of total arsenic in urine, the toxicity of arsenic varies greatly in different speciation. Analysis of arsenic speciation with excessive total arsenic in urine can provide a basis for precise treatment. It can also be used to understand the fate of arsenic in the body of patients with arsenic poisoning after treatment with sodium dimercaptopropane sulfonate. In this study, a HPLC-ICP-MS method was established for the determination of arsenic species in urine samples from patients diagnosed with arsenism. Use the established method to detect urine samples, which can be directly assayed after simple sample dilution with 20 mmol/L EDTA-2Na. With the concentration of arsenic speciation in the range of 1.0~100.0 ng/mL, the linear correlation coefficient was higher than 0.99996. The recoveries were between 92.4% and 109.0%. The precision of the concentration and retention time (n = 3) were less than 3.0% and 0.3%, respectively, and the detection limit was between 1.42 ng/mL and 1.86 ng/mL. This method can be applied to arsenic speciation in the urine of healthy people, in patients treated for arsenic poisoning, and in patients diagnosed with arsenism.